Comparison of the Effects of Ezetimibe-Statin Combination Therapy on Major Adverse Cardiovascular Events in Patients with and without Diabetes: A Meta-Analysis

BACKGROUND: Ezetimibe-statin combination therapy has been found to reduce low density lipoprotein cholesterol levels and the risk of major adverse cardiovascular events (MACEs) in large trials. We sought to examine the differential effect of ezetimibe on MACEs when added to statins according to the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Endocrinol Metab (Seoul)
Asıl Yazarlar: Hong, Namki, Lee, Yong-ho, Tsujita, Kenichi, Gonzalez, Jorge A., Kramer, Christopher M., Kovarnik, Tomas, Kouvelos, George N., Suzuki, Hiromichi, Han, Kyungdo, Lee, Chan Joo, Park, Sung Ha, Lee, Byung-Wan, Cha, Bong-Soo, Kang, Eun Seok
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Korean Endocrine Society 2018
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6021322/
https://ncbi.nlm.nih.gov/pubmed/29766679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3803/EnM.2018.33.2.219
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller